|
IPW expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.49007497849152E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.72184488889116E-12 |
| Stage1-vs-Stage2 |
6.912400E-01 |
| Stage1-vs-Stage3 |
1.148210E-02 |
| Stage1-vs-Stage4 |
3.282500E-02 |
| Stage2-vs-Stage3 |
1.554390E-01 |
| Stage2-vs-Stage4 |
1.813800E-01 |
| Stage3-vs-Stage4 |
7.845000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.50879999996734E-07 |
| Normal-vs-Asian |
5.99239990961564E-10 |
| Caucasian-vs-AfricanAmerican |
3.987400E-01 |
| Caucasian-vs-Asian |
1.047230E-01 |
| AfricanAmerican-vs-Asian |
7.535400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22044604925031E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.035000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.35020000000286E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.214800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.808200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.485400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.928200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.368600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.496600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.70319999717827E-09 |
| Classical-VS-Follicular |
1.717970E-01 |
| Classical-VS-Other |
2.132800E-01 |
| Classical-VS-Normal |
5.92859095149834E-14 |
| Tall-VS-Follicular |
6.52639999820792E-08 |
| Tall-VS-Other |
2.109700E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.524400E-01 |
| Follicular-VS-Normal |
1.76329995049684E-09 |
| Other-VS-Normal |
1.146040E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.43020098173497E-11 |
| N0-vs-N1 |
9.890400E-01 |
|
|
